Clinical trial · Observational
Association Between Hepatitis C Infection and Renal Cell Carcinoma
Association Between Hepatitis C Infection and Renal Cell Carcinoma, a Case Control Study
NCT01405183CI-TRIAL-00015632completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine if there is an association between hepatitis C infection and kidney cancer. All patients who are diagnosed with kidney cancer and who will either have a biopsy or surgery will be offered to be tested for hepatitis C. The control group will be colon cancer patients. Both groups would be of recent diagnosis (6 months).
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
| Hepatitis C | — | UNRESOLVED | — |
| Renal Cell Carcinoma | Renal Cell Carcinoma | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Hepatitis C testing | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Renal Cell Carcinoma patients
- description
- Newly diagnosed (within 6 months) renal cell carcinoma patients in who a biopsy or surgery will be performed
- interventionNames
- Other: Hepatitis C testing
- label
- Colorectal cancer patients
- description
- Newly diagnosed (6 months) colon cancer patients
- interventionNames
- Other: Hepatitis C testing
Primary outcomes (1)
- measure
- Prevalence of hepatitis C in renal cell carcinoma patients
- timeFrame
- 2 years
- description
- Determine the prevalence of hepatitis C infection in newly diagnosed renal cell carcinoma patients
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Male and female patients 18 years or older in whom renal cell carcinoma is suspected and are scheduled for either biopsy or partial or total nephrectomy. Diagnosis within 6 months. * Male and female patients 18 years or older in whom colorectal cancer has been diagnosed within the last 6 months Exclusion Criteria: * Patients who are unwilling to provide consent * Patients who decline to complete a questionnaire * Patient in who blood sample cannot be obtained * Diagnosis of renal cell carcinoma or colon cancer greater than 6 months
References
Publications (1)
- BACKGROUNDGordon SC, Moonka D, Brown KA, Rogers C, Huang MA, Bhatt N, Lamerato L. Risk for renal cell carcinoma in chronic hepatitis C infection. Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):1066-73. doi: 10.1158/1055-9965.EPI-09-1275. Epub 2010 Mar 23. PMID 20332260